Use your antibodies-online credentials, if available.
Il n’y a pas de produits dans votre liste de comparaison.
Votre panier est vide.
The protein encoded by this intronless gene is a bZIP transcription factor which can bind as a homodimer to certain promoters and enhancers. De plus, nous expédions CEBPA Anticorps (154) et CEBPA Protéines (11) et beaucoup plus de produits pour cette protéine.
Showing 10 out of 31 products:
Human CEBPA Kit ELISA pour Sandwich ELISA - ABIN414603
Seipel, Marques, Bozzini, Meinken, Mueller, Pabst: Inactivation of the p53-KLF4-CEBPA Axis in Acute Myeloid Leukemia. dans Clinical cancer research : an official journal of the American Association for Cancer Research 2016
found significantly higher frequencies for NPM1 (Montrer NPM1 Kits ELISA)-mutated 24.2 % and CEBPA-mutated 12.1 %
results demonstrate that the low-level expression of human ACAT2 gene with specific CpG-hypomethylated promoter is regulated by the C/EBP transcription factors in monocytic cells, and imply that the lowly expressed ACAT2 catalyzes the synthesis of certain CE/SE that are assembled into lipoproteins for the secretion
Our study highlighted two novel promoter KLF1 and 3'-region C/EBPalpha motifs in the phenylalanine hydroxylase (PAH) gene which decrease transcription in vitro and, thus, could be considered as PAH expression modifiers.
The QA repeat domain of TCERG1 (Montrer TCERG1 Kits ELISA) is required for relocalization of CEBPalpha.
In the CCAAT/enhancer binding protein alpha gene, no mutations were detected but a known polymorphism (c.584_589dup ACCCGC) was observed in 26 (28.3%) patients.
The p53 (Montrer TP53 Kits ELISA)-KLF4 (Montrer KLF4 Kits ELISA)-CEBPA axis is deregulated in AML (Montrer RUNX1 Kits ELISA) but can be functionally restored by conventional chemotherapy and novel p53 (Montrer TP53 Kits ELISA) activating treatments.
C/EBPalpha inhibited breast cancer cell growth via a novel miR (Montrer MLXIP Kits ELISA)-134/CREB (Montrer CREB1 Kits ELISA) signaling pathway.
C/EBP-alpha was primarily expressed in hepatocytes in normal liver, but its expression decreased significantly in liver fibrosis
The efficient repression of E2F (Montrer E2F1 Kits ELISA) dependent S-phase genes and the activation of differentiation genes reside in the balanced DNA binding capacity of C/EBP alpha.
we are the first to identify that miR (Montrer MLXIP Kits ELISA)-381 suppresses C/EBPalpha-dependent Cx43 (Montrer GJA1 Kits ELISA) expression in breast cancer cells. The miR (Montrer MLXIP Kits ELISA)-381-C/EBPalpha-Cx43 (Montrer GJA1 Kits ELISA) axis might be a useful diagnostic and therapeutic target of metastatic breast cancer
the DNA sequences to which EVI1 (Montrer MECOM Kits ELISA) binds at +35 and +37 kb and show that mutation of one of these releases Cebpa from EVI1 (Montrer MECOM Kits ELISA)-induced suppression.
Cebpa enhancers and silencers in a transcriptional model have roles in hematopoietic lineage specification
Data show that CCAAT-enhancer-binding protein-alpha (C/EBPalpha) directly regulates Kruppel-like factor 4 (Klf4 (Montrer KLF4 Kits ELISA)) expression and increasing the levels of histone demethylase (Montrer MBD2 Kits ELISA) Lsd1 (Montrer KDM1A Kits ELISA) and transcription factor Brd4 (Montrer BRD4 Kits ELISA) in B cell.
The findings demonstrate a critical role for the +37 kb Cebpa enhancer for hematopoietic-specific Cebpa expression, with enhancer deletion leading to impaired myelopoiesis and potentially preleukemic progenitor expansion.
Data indicate that miR (Montrer MLXIP Kits ELISA)-25 is a novel negative regulator of adipocyte differentiation and it suppressed 3T3-L1 adipogenesis by targeting KLF4 (Montrer KLF4 Kits ELISA) and C/EBPalpha, which provides novel insights into the molecular mechanism of miRNA-mediated cellular differentiation.
MYB (Montrer MYB Kits ELISA) and C/EBPalpha activities are inter-dependent in controlling Flt3 (Montrer FLT3 Kits ELISA) expression to influence lineage commitment of multipotential progenitors.
Data indicate that white adipose tissue from IgE receptor FcR1-deficient Fcer1a (Montrer FCER1A Kits ELISA)(-/-) mice showed an increased expression of CCAAT-enhancer-binding protein-alpha (C-EBPalpha) and peroxisome proliferator-activated receptor-gamma (PPARgamma (Montrer PPARG Kits ELISA)).
miR (Montrer MLXIP Kits ELISA)-223 regulates adipocyte and osteoblast differentiation through a novel C/EBPs/miR (Montrer MLXIP Kits ELISA)-223/FGFR2 (Montrer FGFR2 Kits ELISA) regulatory feedback loop.
Data (including data from studies in transgenic/mutant mice) suggest Cebpa (CCAAT-enhancer binding protein alpha) in myeloid cells is down-regulated in type 2 diabetes resulting in poor maturation of Gr-1 (Montrer GSR Kits ELISA)+ (chemokine receptor (Montrer CCR1 Kits ELISA)) myeloid cells.
C/ebpalpha plays a role in liver growth regulation via the p53 (Montrer TP53 Kits ELISA) pathway.
Dnmt1 (Montrer DNMT1 Kits ELISA) is required for hematopoietic stem and progenitor cells maintenance via cebpa regulation during definitive hematopoiesis in zebrafish
Data suggest that upregulation of 10-formyltetrahydrofolate dehydrogenase (FDH (Montrer ALDH1L1 Kits ELISA)) involving CEBPalpha helps relieve embryonic oxidative stress induced (Montrer SQSTM1 Kits ELISA) by ethanol exposure.
Bmi1 (Montrer BMI1 Kits ELISA) acts immediately downstream of CCAAT enhancer binding protein-alpha to regulate the survival and self-renewal of hematopoietic stem cells and contribute to the erythropoietic dysplasia.
Results provide first evidence that sumoylation of Cebp-alpha (via SUMO1 (Montrer SUMO1 Kits ELISA), SUMO2 (Montrer SUMO2 Kits ELISA), and SUMO3 (Montrer SUMO3 Kits ELISA)) might contribute to cell fate decision of myelo-erythroid progenitor cells in intermediate cell mass during primitive [extramedullary] hematopoiesis.
An evolutionarily conserved PTEN-C/EBPalpha-CTNNA1 (Montrer CTNNA1 Kits ELISA) axis controls myeloid development and transformation.
a C/EBP recognition sequence in the proximal promoter region of C/EBPalpha is essential for IL-6 (Montrer IL6 Kits ELISA)-mediated repression
These results suggest that the CEBPA gene is a strong candidate gene that affects carcass traits in Qinchuan cattle.
Expressions of C-EBPalpha and myostatin (Montrer MSTN Kits ELISA) in muscles were higher in the concentrate-fed group than in the grass hay (Montrer GTF2H5 Kits ELISA)-fed group.
C/EBPalpha is an essential regulatory factor for perilipin5 transcription and suggest that fasting stimulates perilipin5 transcription through influencing C/EBPalpha expression.
The differential expression of specific CEBPA/B isoforms observed in maturing follicles and CL may contribute to changes in follicular cell differentiation and increasing steroidogenic capacity.
The protein encoded by this intronless gene is a bZIP transcription factor which can bind as a homodimer to certain promoters and enhancers. It can also form heterodimers with the related proteins CEBP-beta and CEBP-gamma. The encoded protein has been shown to bind to the promoter and modulate the expression of the gene encoding leptin, a protein that plays an important role in body weight homeostasis. Also, the encoded protein can interact with CDK2 and CDK4, thereby inhibiting these kinases and causing growth arrest in cultured cells.
CCAAT/enhancer-binding protein alpha
, C/EBP alpha
, CAAT/enhancer-binding protein DNA-binding protein
, CAAT/enhancer-binding protein, DNA-binding protein
, CCAAT/enhancer binding protein, alpha
, c/EBP alpha
, CCAAT/enhancer binding protein alpha